Cassava Sciences Inc $71,161,394 Mabvax Therapeutics Holdings Inc $272,550 Amylin Pharmaceuticals Inc $0 MGIC Investment Corp $216,294,855 Sarepta Therapeutics Inc $734,905,140 Cassava Sciences Inc $71,161,394 Mabvax Therapeutics Holdings Inc $272,550 Amylin Pharmaceuticals Inc $0 MGIC Investment Corp $216,294,855 Sarepta Therapeutics Inc $734,905,140